Authors: Dr Romina Oxborough • Dale Bushell

Published by: Maprium & VAT IT

VAT, customs and tariffs are becoming harder to separate from the day-to-day reality of running a global Managed Access Program.

From changing EU VAT requirements to US tariffs, the way medicines move across borders can create unexpected costs, compliance risks and missed recovery opportunities.

Our latest article, produced with VAT IT, explores what pharma teams need to understand — and why tax considerations should be built into MAP planning from the outset.

Download the PDF to explore the key issues, risks and opportunities for global Managed Access Programs.